Sumant Ramachandra Email

CEO . ImmPACT Bio USA

Los Angeles, CA

Location

LinkedIn

Current Roles

Employees:
88
Revenue:
$0
About
ImmPACT-Bio is pioneering a novel strategy to surmount a major challenge compromising current Chimeric Antigen Receptor T-cell (CAR-T) therapy. Our technology addresses the need to differentiate cancerous from non-cancerous tissues impacting the safety of the treatment which is to date a major limitation in reaching effectiveness. The company’s technology is based on the work of Prof. Gideon Gross (MIGAL – Galilee Research Institute), who is one of the pioneers of the world’s first CAR-T construct.
ImmPACT Bio USA Address

Los Angeles, CA
United States
ImmPACT Bio USA Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.